Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

157.36 -6.92 (-4.21%)

Streaming Delayed Price Updated: 10:19 AM EDT, Jul 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,347,290
Open	163.89
Bid (Size)	157.32 (300)
Ask (Size)	157.40 (300)
Prev. Close	164.28
Today's Range	157.26 - 164.23
52wk Range	84.39 - 165.71
Shares Outstanding	541,500
Dividend Yield	0.18%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗

July 09, 2026

PJP delivers lower volatility and higher income with concentrated pharma exposure, while XBI offers broader biotech growth at lower cost.

Via The Motley Fool

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best? ↗

July 05, 2026

One offers broad stability with lower costs and higher income, while the other chases biotech growth with 89.3% annual returns but steeper volatility.

Via The Motley Fool

Performance

YTD	+29.5%	+29.5%
1 Month	+19.8%	+19.8%
3 Month	+19.4%	+19.4%
6 Month	+27.2%	+27.2%
1 Year	+79.1%	+79.1%

More News

The Best Biotech Stocks to Buy in 2026 ↗

June 17, 2026

Via The Motley Fool

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? ↗

June 17, 2026

Via The Motley Fool

3 Longevity ETFs to Buy and Hold (and Hold) ↗

June 08, 2026

Via MarketBeat

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗

June 05, 2026

Via The Motley Fool

VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost ↗

May 28, 2026

Via The Motley Fool

2 Ways to Play the Big Pharma Patent Cliff ↗

May 15, 2026

Via MarketBeat

Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge

March 23, 2026

Via MarketMinute

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗

March 21, 2026

Via The Motley Fool

IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins ↗

March 17, 2026

Via Stocktwits

The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)

March 12, 2026

Via Finterra

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? ↗

March 11, 2026

Via Stocktwits

QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗

March 10, 2026

Via Stocktwits

QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗

March 10, 2026

Via Stocktwits

QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗

March 09, 2026

Via Stocktwits

IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data ↗

March 09, 2026

Via Stocktwits

ALT Stock Drops On Wider-Than-Expected Q4 Loss: Retail Voices Hopes For Deal To Alleviate Cash Concerns ↗

March 05, 2026

Via Stocktwits

Why Did CRMD Stock Tumble Over 11% Today? ↗

March 05, 2026

Via Stocktwits

Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗

March 05, 2026

Via Stocktwits

Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth ↗

March 05, 2026

Via Stocktwits

DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗

March 04, 2026

Via Stocktwits

IBRX Stock Drops On Investor Concerns Over Immunotherapy Launch In Saudi Arabia Amid Middle East Tensions But Analyst Sees 20% Upside ↗

March 04, 2026

Via Stocktwits

Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Why Did QURE Stock Almost Halve Pre-Market Today? ↗

March 02, 2026

Via Stocktwits

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?

Yes, State Street SPDR S&P Biotech ETF is publicly traded.

What exchange does State Street SPDR S&P Biotech ETF trade on?

State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange

What is the ticker symbol for State Street SPDR S&P Biotech ETF?

The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange

What is the current price of State Street SPDR S&P Biotech ETF?

The current price of State Street SPDR S&P Biotech ETF is 157.36

When was State Street SPDR S&P Biotech ETF last traded?

The last trade of State Street SPDR S&P Biotech ETF was at 07/10/26 10:19 AM ET

What is the market capitalization of State Street SPDR S&P Biotech ETF?

The market capitalization of State Street SPDR S&P Biotech ETF is 85.21M

How many shares of State Street SPDR S&P Biotech ETF are outstanding?

State Street SPDR S&P Biotech ETF has 85M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.